231 related articles for article (PubMed ID: 36700145)
1. Soluble epoxide hydrolase inhibition alleviates chemotherapy induced neuropathic pain.
Takeshita AA; Hammock BD; Wagner KM
Front Pain Res (Lausanne); 2022; 3():1100524. PubMed ID: 36700145
[TBL] [Abstract][Full Text] [Related]
2. Soluble epoxide hydrolase inhibition is antinociceptive in a mouse model of diabetic neuropathy.
Wagner K; Yang J; Inceoglu B; Hammock BD
J Pain; 2014 Sep; 15(9):907-14. PubMed ID: 24924124
[TBL] [Abstract][Full Text] [Related]
3. Epoxy fatty acids mediate analgesia in murine diabetic neuropathy.
Wagner K; Lee KS; Yang J; Hammock BD
Eur J Pain; 2017 Mar; 21(3):456-465. PubMed ID: 27634339
[TBL] [Abstract][Full Text] [Related]
4. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Stress Axis-Dependence of Duloxetine Analgesia (Anti-Hyperalgesia) in Chemotherapy-Induced Peripheral Neuropathy.
Staurengo-Ferrari L; Bonet IJM; Araldi D; Green PG; Levine JD
J Neurosci; 2022 Jan; 42(3):405-415. PubMed ID: 34880120
[TBL] [Abstract][Full Text] [Related]
6. Neuropathic Pain and Nerve Growth Factor in Chemotherapy-Induced Peripheral Neuropathy: Prospective Clinical-Pathological Study.
Velasco R; Navarro X; Gil-Gil M; Herrando-Grabulosa M; Calls A; Bruna J
J Pain Symptom Manage; 2017 Dec; 54(6):815-825. PubMed ID: 28797868
[TBL] [Abstract][Full Text] [Related]
7. EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model.
Liu T; Li T; Chen X; Li Z; Feng M; Yao W; Wan L; Zhang C; Zhang Y
J Neuroinflammation; 2021 Sep; 18(1):211. PubMed ID: 34530836
[TBL] [Abstract][Full Text] [Related]
8. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
9. Soluble epoxide hydrolase inhibitor mediated analgesia lacks tolerance in rat models.
Wagner KM; Atone J; Hammock BD
Brain Res; 2020 Feb; 1728():146573. PubMed ID: 31790682
[TBL] [Abstract][Full Text] [Related]
10. Prevention and Management of Chemotherapy-Induced Polyneuropathy.
Jordan B; Jahn F; Sauer S; Jordan K
Breast Care (Basel); 2019 Apr; 14(2):79-84. PubMed ID: 31798378
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
[TBL] [Abstract][Full Text] [Related]
12. Pharmaceutical Effects of Inhibiting the Soluble Epoxide Hydrolase in Canine Osteoarthritis.
McReynolds CB; Hwang SH; Yang J; Wan D; Wagner K; Morisseau C; Li D; Schmidt WK; Hammock BD
Front Pharmacol; 2019; 10():533. PubMed ID: 31214021
[TBL] [Abstract][Full Text] [Related]
13. Comparative analgesic efficacy of pregabalin administered according to either a prevention protocol or an intervention protocol in rats with cisplatin-induced peripheral neuropathy.
Han FY; Kuo A; Nicholson JR; Corradinni L; Smith MT
Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):1067-1075. PubMed ID: 29781509
[TBL] [Abstract][Full Text] [Related]
14. Informative gene network for chemotherapy-induced peripheral neuropathy.
Reyes-Gibby CC; Wang J; Yeung SJ; Shete S
BioData Min; 2015; 8():24. PubMed ID: 26269716
[TBL] [Abstract][Full Text] [Related]
15. Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives.
Poupon L; Kerckhove N; Vein J; Lamoine S; Authier N; Busserolles J; Balayssac D
Expert Opin Drug Saf; 2015 Aug; 14(8):1269-82. PubMed ID: 26058312
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal Antibody Targeting the Matrix Metalloproteinase 9 Prevents and Reverses Paclitaxel-Induced Peripheral Neuropathy in Mice.
Tonello R; Lee SH; Berta T
J Pain; 2019 May; 20(5):515-527. PubMed ID: 30471427
[TBL] [Abstract][Full Text] [Related]
17. The analgesic effect of orexin-A in a murine model of chemotherapy-induced neuropathic pain.
Toyama S; Shimoyama N; Shimoyama M
Neuropeptides; 2017 Feb; 61():95-100. PubMed ID: 28041630
[TBL] [Abstract][Full Text] [Related]
18. Therapeutics for Chemotherapy-Induced Peripheral Neuropathy: Approaches with Natural Compounds from Traditional Eastern Medicine.
Chung G; Kim SK
Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890302
[TBL] [Abstract][Full Text] [Related]
19. Acupuncture for Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Survivors: A Randomized Controlled Pilot Trial.
Lu W; Giobbie-Hurder A; Freedman RA; Shin IH; Lin NU; Partridge AH; Rosenthal DS; Ligibel JA
Oncologist; 2020 Apr; 25(4):310-318. PubMed ID: 32297442
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study.
Selvy M; Kerckhove N; Pereira B; Barreau F; Nguyen D; Busserolles J; Giraudet F; Cabrespine A; Chaleteix C; Soubrier M; Bay JO; Lemal R; Balayssac D
Front Pharmacol; 2021; 12():637593. PubMed ID: 33967771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
